|
|
|
|
|
|
Risk Management, Labeling Decision-Making,
Personalized Medicine, and Knowledge-based Clinical Decision Support | | | Interactive pragmatic workshops and
forum led by our world-leading medical faculty instructors
a 3 Day InnovationWell Drug Safety Workshop
3-5 July 2006; Oxford University, Oxford, UK
led by Saad Shakir, Director, Drug Safety Research Unit, UK
A. Leander Fontaine, President, pharmiceutics
Peter Elkin, Professor of Medicine, Mayo Clinic
Supported by expert advisory panel in knowledge management,
organisational development and biomedical informatics | Work through and discuss complex case-studies, strategies and emerging best practices with leading safety and medical experts!
Risk Management Planning
Integrating Clinical Development & Pharmacovigilance Planning
Communication of Drug Safety Issues
Safety Evaluation and Outcomes
Managing Spontaneous Reporting
Responding to new US and EU Labeling Regulations & Guidelines
Proactive Drug Safety Knowledge Management
Decision Support for Research and Practice of Medicine
Latest Advances in Pharmacogenomics & Personalised Medicine
These workshops are aimed to bring leading best practice and issue discussion to practitioners in the healthcare industry working in the increasingly integrated cross-functional area of proactive drug and patient safety management. Workshop groups will work through and discuss complex issues highlighted by detailed case studies presented by instructors.
Healthcare providers, program managers, clinical development management, safety & pharmacovigilance experts, product managers, clinical and regulatory affairs, and post-marketing support will all take-away key nuggets of understanding in this fast-evolving field and will have ample opportunity to share and discuss their different perspectives.
|
Workshop Program
Monday July 3 9.00 – 17.00
Practical Strategies for Risk Characterisation, Assessment and Management of Medicinal Products
Led by Professor Saad Shakir, Director, Drug Safety Research Unit, UK
More Information....
Tuesday July 4 9.00 – 17.00
Safety Labeling Decision-Making and Regulatory Implementation
Led by A Leander Fontaine, President, Pharmiceutics
More Information....
Wednesday July 5 9.00 – 17.00
Latest Advances in Pharmacogenomics, Personalised Medicine and Decision Support for Research and Practice of Medicine
Led by Professor Peter Elkin, Mayo Clinic
More Information....
Location:
The workshops will take place at the Chemistry Research Laboratory, Oxford University, Oxford, UK.
This new state of the art facility provides 17,000 sq meters of research space to 400 researchers and at a cost of more than £60M is the largest capital project undertaken by Oxford University to date.
| | A virtual tour of the facility is available at http://www.chem.ox.ac.uk/oxfordtour/crl/ |
|
|
| For further information and questions on Workshop & Training programs and registration, please contact Dr. Barry Hardy at: barry.hardy [at] douglasconnect.com, Tel: +41 61 851 0170 |
|
|
|
|
|
|
|
